Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis

Abstract Background Radiographic progression and course of inflammation over 2 years in patients with non-radiographic axial spondyloarthritis (nr-axSpA) from the phase 3, randomized, PREVENT study are reported here. Methods In the PREVENT study, adult patients fulfilling the Assessment of SpondyloA...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Juergen Braun, Ricardo Blanco, Helena Marzo-Ortega, Lianne S. Gensler, Filip Van den Bosch, Stephen Hall, Hideto Kameda, Denis Poddubnyy, Marleen van de Sande, Désirée van der Heijde, Tingting Zhuang, Anna Stefanska, Aimee Readie, Hanno B. Richards, Atul Deodhar
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2023-05-01
Edice:	Arthritis Research & Therapy
Témata:	Axial spondyloarthritis Non-radiographic axial spondyloarthritis Nr-axSpA Secukinumab X-ray Radiograph
On-line přístup:	https://doi.org/10.1186/s13075-023-03051-5
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!